Skip to content
Genalyte, Inc. logo — Transform the doctor-patient relationship by bringing the do...

Genalyte, Inc.

Transform the doctor-patient relationship by bringing the doctor, the patient, and the lab together to provide results when they matter

Founded 2007 United States San Diego, United States 91 employees Total: $141.80M Biotechnology, Health Care

General Information

Company Name Genalyte, Inc.
Founded Year 2007
Location United States San Diego, United States
Founders / Decision Makers
Team member Team member
Employees 91
Industries Biotechnology, Health Care
Social

BounceWatch is an independent company data service, not affiliated with Genalyte, Inc.. To contact Genalyte, Inc., visit genalyte.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Genalyte, Inc. compare?

A PDF of Genalyte, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Genalyte, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Genalyte, Inc.

Genalyte, Inc. is a pioneering **tech-enabled, full service CAP accredited and CLIA certified laboratory** with a focus on providing rapid and comprehensive testing solutions. Founded in **2007**, the company operates in the **Biotechnology** and **Health Care** sectors, with its headquarters in the **United States**. Their latest milestone includes a significant **$13.00M Series C investment** secured on **07 March 2023** from **HBM Partners**. Genalyte's innovative approach is centered around their proprietary **Maverick platform**, which received FDA clearance in Oct 2019 and enables simultaneous immunoassays on whole blood - a process that can deliver results in just 15 minutes. With the current focus on health needs, the company has developed a rapid **COVID-19 serology test** for IgG and IgM antibodies, demonstrating a commitment to addressing critical healthcare challenges. Their unique ability to conduct the majority of tests within 30 minutes using a mobile laboratory, in addition to a central lab for more complex tests, showcases their versatility and commitment to providing quality and efficient testing services. For more information, visit www.genalyte.com.

Business keywords: diagnostic testing, laboratory services, serological testing, immunoassays, point-of-care testing, COVID-19 testing, technology-enabled healthcare, telehealth platform, FDA clearance, clinical diagnostics, cloud-based healthcare solutions

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Late VC $50.00M 5
Khosla Ventures, Redmile Group +3
01 Jan 2021
Series D $36.00M 2
Khosla Ventures, Redmile Group
01 Nov 2016
Series C $44.00M 5
Claremont Creek Ventures, Khosla Ventures +3
01 Aug 2015
Series B $11.80M 1
Claremont Creek Ventures
01 Mar 2012
Spinout Undisclosed 1
CalTech
01 Jan 2007

Genalyte, Inc. Alternatives & Competitors

View All Alternatives
Genalyte, Inc. vs
Beacon Biomedical
Beacon Biomedical United States

Easy, Accurate & Affordable Blood Based Screening for early detection of cancer and COVID-19 detecti...

Acquired
1 employees
Biotechnology, Health Care
Genalyte, Inc. vs
Senzo Health
Senzo Health United States

PCR-Accurate Lateral Flow Testing

8 employees
Biotechnology, Health Care
Genalyte, Inc. vs

Taking Point-of-Care testing to the next level.

Grant
11 employees
Biotechnology, Health Care

FAQ About Genalyte, Inc.

Transform the doctor-patient relationship by bringing the doctor, the patient, and the lab together to provide results when they matter
Genalyte, Inc. was founded in 2007.
Genalyte, Inc. is headquartered in San Diego, United States.
Genalyte, Inc. operates in Biotechnology and Health Care. Its work centres on diagnostic testing, laboratory services, serological testing and immunoassays.
Genalyte, Inc. has approximately 91 employees.
Genalyte, Inc. has completed 5 funding rounds, raising a total of $141.80M.
Top alternatives and competitors to Genalyte, Inc. include Beacon Biomedical, Senzo Health, FRIZ Biochem GmbH, Biosense Technologies , Haemokinesis. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Genalyte, Inc. and Beacon Biomedical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Genalyte, Inc., https://bouncewatch.com/company/genalyte-inc, updated 9 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout